Sun Pharmaceutical Industries Ltd. et al v. Saptalis Pharmaceuticals, LLC
| Sun Pharmaceutical Industries Ltd. and Ranbaxy Signature, LLC |
| Saptalis Pharmaceuticals, LLC |
| 2:2018cv02545 |
| April 30, 2018 |
| US District Court for the Eastern District of New York |
| Central Islip Office |
| Joan M. Azrack |
| Patent |
| 28 U.S.C. ยง 1338 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 30, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 1 COMPLAINT against Saptalis Pharmaceuticals, LLC filing fee $ 400, receipt number 0207-10394740 Was the Disclosure Statement on Civil Cover Sheet completed -Yes,, filed by Sun Pharmaceutical Industries Ltd., Ranbaxy Signature, LLC. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons, #3 Exhibit A - 957 patent) (Park, Samuel) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
